<H1>Chapter DOI: 10.1208/aapsj070235<br/>Cited-By Count: 75</H1><table border="1" width="30%"><tr><td>Total References</td><td>76</td></tr><tr><td>Springer references</td><td>2</td></tr><tr><td>Non Springer references</td><td>74</td></tr><tr><td>BibStructured Count</td><td width="10%">76</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>63</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>2</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>2</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>2</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Walaas SI, Aswad DW, Greengard P. A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions.<Emphasis Type="Italic">Nature</Emphasis>. 1983;301:69&#8211;71.</td><td><a href=http://dx.doi.org/10.1038/301069a0>10.1038/301069a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Hemmings HC Jr, Greengard P, Tung HY, Cohen P. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.<Emphasis Type="Italic">Nature</Emphasis>. Aug 9&#8211;15, 1984;310(5977):503&#8211;505.</td><td><a href=http://dx.doi.org/10.1038/310503a0>10.1038/310503a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Ouimet CC, Langley-Gullion KC, Greengard P. Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen.<Emphasis Type="Italic">Brain Res.</Emphasis> 1998;808:8&#8211;12.</td><td><a href=http://dx.doi.org/10.1016/S0006-8993(98)00724-0>10.1016/S0006-8993(98)00724-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>da Cruz e Silva EF, Fox CA, Ouimet CC, Gustafson E, Watson SJ, Greengard P. Differential expression of protein phosphatase 1 isoforms in mammalian brain.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1995;15:3375&#8211;3389.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Girault JA Jr, Hemmings HC Jr, Williams KR, Nairn AC, Greengard P. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 1989;264:21748&#8211;21759.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Desouits F, Cohen D, Nairn AC, Greengard P, Girault JA. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase I in vitro and in vivo.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 1995;270:8772&#8211;8778.</td><td><a href=http://dx.doi.org/10.1074/jbc.270.15.8772>10.1074/jbc.270.15.8772</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Desdouits F, Siciliano JC, Greengard P, Girault JA. Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 1995;92:2682&#8211;2685.</td><td><a href=http://dx.doi.org/10.1073/pnas.92.7.2682>10.1073/pnas.92.7.2682</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Bibb JA, Snyder GL, Nishi A, et al. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.<Emphasis Type="Italic">Nature</Emphasis>. 1999;402:669&#8211;671.</td><td><a href=http://dx.doi.org/10.1038/45251>10.1038/45251</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Ouimet CC, Jr, Miller PE Jr, Hemmings HC Jr, Walaas SI, Greengard P. DARPP-32, a dopamine- and adenosine 3&#8242;:5&#8242;-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III Immunocytochemical localization.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1984;4:111&#8211;124.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Yoshida M, Precht W. Monosynaptic inhibition of neurons of the substantia nigra by caudato-nigral fibers.<Emphasis Type="Italic">Brain Res.</Emphasis> 1971;32:225&#8211;228.</td><td><a href=http://dx.doi.org/10.1016/0006-8993(71)90170-3>10.1016/0006-8993(71)90170-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Beckstead RM, Cruz CJ. Striatal axons to the globus pallidus, entopeduncular nucleus and substantia nigra come mainly from separate cell populations in cat.<Emphasis Type="Italic">Neuroscience</Emphasis>. 1986;19:147&#8211;158.</td><td><a href=http://dx.doi.org/10.1016/0306-4522(86)90012-6>10.1016/0306-4522(86)90012-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Gerfen CR 3rd, Young WS 3rd. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study.<Emphasis Type="Italic">Brain Res.</Emphasis> 1988;460:161&#8211;167.</td><td><a href=http://dx.doi.org/10.1016/0006-8993(88)91217-6>10.1016/0006-8993(88)91217-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Kawaguchi Y, Wilson CJ, Emson PC. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1990;10:3421&#8211;3438.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Anderson KD, Reiner A. Immunohistochemical localization of DARPP-32 in striatal projection neurons and striatal interneurons: implications for the localization of D1-like dopamine receptors on different types of striatal neurons.<Emphasis Type="Italic">Brain Res.</Emphasis> 1991;568:235&#8211;243.</td><td><a href=http://dx.doi.org/10.1016/0006-8993(91)91403-N>10.1016/0006-8993(91)91403-N</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Ouimet CC, Greengard P. Distribution of DARPP-32 in the basal ganglia: an electron microscopic study.<Emphasis Type="Italic">J Neurocytol.</Emphasis> 1990;19:39&#8211;52.</td><td><a href=http://dx.doi.org/10.1007/BF01188438>10.1007/BF01188438</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Carboni E, Imperato A, Perezzani L, Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensive increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.<Emphasis Type="Italic">Neuroscience.</Emphasis> 1989;28:653&#8211;661.</td><td><a href=http://dx.doi.org/10.1016/0306-4522(89)90012-2>10.1016/0306-4522(89)90012-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Parsons LH, Koob GF, Weiss F. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1995;274:1182&#8211;1191.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P. DARPP-32: an integrator of neurotransmission.<Emphasis Type="Italic">Annu Rev Pharmacol Toxicol.</Emphasis> 2004;44:269&#8211;296.</td><td><a href=http://dx.doi.org/10.1146/annurev.pharmtox.44.101802.121415>10.1146/annurev.pharmtox.44.101802.121415</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Stoof JC, Kebabian JW. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum.<Emphasis Type="Italic">Nature</Emphasis>. 1981;294:366&#8211;368.</td><td><a href=http://dx.doi.org/10.1038/294366a0>10.1038/294366a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Bergson C, Levenson R, Goldman-Rakic PS, Lidow MS. Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling.<Emphasis Type="Italic">Trends Pharmacol Sci.</Emphasis> 2003;24:486&#8211;492.</td><td><a href=http://dx.doi.org/10.1016/S0165-6147(03)00232-3>10.1016/S0165-6147(03)00232-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Nishi A, Snyder GL, Greengard P. Bidirectional regulation of DARPP-32 phosphorylation by dopamine.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1997;17:8147&#8211;8155.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Gerfen CR, Engber TM, Mahan LC, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.<Emphasis Type="Italic">Science.</Emphasis> 1990;250:1429&#8211;1432.</td><td><a href=http://dx.doi.org/10.1126/science.2147780>10.1126/science.2147780</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Surmeier DJ, Song WJ, Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1996;16:6579&#8211;6591.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1016/S1054-3589(08)60921-7>10.1016/S1054-3589(08)60921-7</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Aizman O, Brismar H, Uhlen P, et al. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons.<Emphasis Type="Italic">Nat Neurosci.</Emphasis> 2000;3:226&#8211;230.</td><td><a href=http://dx.doi.org/10.1038/72929>10.1038/72929</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Svenningsson P, Lindskog M, Ledent C, et al. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2000;97:1856&#8211;1860.</td><td><a href=http://dx.doi.org/10.1073/pnas.97.4.1856>10.1073/pnas.97.4.1856</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Lindskog M, Svenningsson P, Fredholm BB, Greengard P, Fisone G. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms.<Emphasis Type="Italic">Neuroscience</Emphasis>. 1999;88:1005&#8211;1008.</td><td><a href=http://dx.doi.org/10.1016/S0306-4522(98)00411-4>10.1016/S0306-4522(98)00411-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Nishi A, Bibb JA, Snyder GL, Higashi H, Nairn AC, Greengard P. Amplification of dopaminergic signaling by a positive feedback loop.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2000;97:12840&#8211;12845.</td><td><a href=http://dx.doi.org/10.1073/pnas.220410397>10.1073/pnas.220410397</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Halpain S, Girault JA, Greengard P. Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices.<Emphasis Type="Italic">Nature</Emphasis>. 1990;343:369&#8211;372.</td><td><a href=http://dx.doi.org/10.1038/343369a0>10.1038/343369a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Nishi A, Bibb JA, Matsuyama S, et al. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A.<Emphasis Type="Italic">J Neurochem.</Emphasis> 2002;81:832&#8211;841.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.2002.00876.x>10.1046/j.1471-4159.2002.00876.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Schoepp DD, Jane DE, Monn JA. Pharmacological agents acting at subtypes of metabotropic glutamate receptors.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 1999;38:1431&#8211;1476.</td><td><a href=http://dx.doi.org/10.1016/S0028-3908(99)00092-1>10.1016/S0028-3908(99)00092-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Tallaksen-Greene SJ, Kaatz KW, Romano C, Albin RL. Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons.<Emphasis Type="Italic">Brain Res.</Emphasis> 1998;780:210&#8211;217.</td><td><a href=http://dx.doi.org/10.1016/S0006-8993(97)01141-4>10.1016/S0006-8993(97)01141-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Testa CM, Friberg IK, Weiss SW, Standaert DG. Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia.<Emphasis Type="Italic">J Comp Neurol.</Emphasis> 1998;390:5&#8211;19.</td><td><a href=http://dx.doi.org/10.1002/(SICI)1096-9861(19980105)390:1&lt;5::AID-CNE2&gt;3.0.CO;2-6>10.1002/(SICI)1096-9861(19980105)390:1&lt;5::AID-CNE2&gt;3.0.CO;2-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Nishi A, Liu F, Matsuyama S, et al. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2003;100:1322&#8211;1327.</td><td><a href=http://dx.doi.org/10.1073/pnas.0237126100>10.1073/pnas.0237126100</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Liu F, Ma XH, Ule J, et al. Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2001;98:11062&#8211;11068.</td><td><a href=http://dx.doi.org/10.1073/pnas.191353898>10.1073/pnas.191353898</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Liu F, Virshup DM, Nairn AC, Greengard P. Mechanism of regulation of casein kinase I activity by group I metabotropic glutamate receptors.<Emphasis Type="Italic">J Biol Chem.</Emphasis> 2002;277:45393&#8211;45399.</td><td><a href=http://dx.doi.org/10.1074/jbc.M204499200>10.1074/jbc.M204499200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Nishi A, Watanabe Y, Higashi H, Tanaka M, Nairn AC, Greengard P. Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2005;102:1199&#8211;1204.</td><td><a href=http://dx.doi.org/10.1073/pnas.0409138102>10.1073/pnas.0409138102</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Barnes NM, Sharp T. A review of central 5-HT receptors and their function.<Emphasis Type="Italic">Neuropharmacology.</Emphasis> 1999;38:1083&#8211;1152.</td><td><a href=http://dx.doi.org/10.1016/S0028-3908(99)00010-6>10.1016/S0028-3908(99)00010-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Svenningsson P, Tzavara ET, Liu F, Fienberg AA, Nomikos GG, Greengard P. DARPP-32 mediates serotonergic neurotransmission in the forebrain.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2002;99:3188&#8211;3193.</td><td><a href=http://dx.doi.org/10.1073/pnas.052712699>10.1073/pnas.052712699</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Schiffmann SN, Jacobs O, Vanderhaeghen JJ. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study.<Emphasis Type="Italic">J Neurochem.</Emphasis> 1991;57:1062&#8211;1067.</td><td><a href=http://dx.doi.org/10.1111/j.1471-4159.1991.tb08257.x>10.1111/j.1471-4159.1991.tb08257.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Svenningsson P, Lindskog M, Rognoni F, Fredholm BB, Greengard P, Fisone G. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons.<Emphasis Type="Italic">Neuroscience</Emphasis>. 1998;84:223&#8211;228.</td><td><a href=http://dx.doi.org/10.1016/S0306-4522(97)00510-1>10.1016/S0306-4522(97)00510-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Lindskog M, Svenningsson P, Pozzi L, et al. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine.<Emphasis Type="Italic">Nature</Emphasis>. 2002;418:774&#8211;778.</td><td><a href=http://dx.doi.org/10.1038/nature00817>10.1038/nature00817</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Hyman SE, Malenka RC. Addiction and the brain: the neurobiology of compulsion and its persistence.<Emphasis Type="Italic">Nat Rev Neurosci.</Emphasis> 2001;2:695&#8211;703.</td><td><a href=http://dx.doi.org/10.1038/35094560>10.1038/35094560</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Nestler EJ. Molecular basis of long-term plasticity underlying addiction.<Emphasis Type="Italic">Nat Rev Neurosci.</Emphasis> 2001;2:119&#8211;128.</td><td><a href=http://dx.doi.org/10.1038/35053570>10.1038/35053570</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Fienberg AA, Hiroi N, Mermelstein PG, et al. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.<Emphasis Type="Italic">Science</Emphasis>. 1998;281:838&#8211;842.</td><td><a href=http://dx.doi.org/10.1126/science.281.5378.838>10.1126/science.281.5378.838</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Svenningsson P, Tzavara ET, Carruthers R, et al. Diverse psychotomimetics act through a common on signaling pathway.<Emphasis Type="Italic">Science</Emphasis>. 2003;302:1412&#8211;1415.</td><td><a href=http://dx.doi.org/10.1126/science.1089681>10.1126/science.1089681</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Fienberg AA, Greengard P. The DARPP-32 knockout mouse.<Emphasis Type="Italic">Brain Res Brain Res Rev.</Emphasis> 2000;31:313&#8211;319.</td><td><a href=http://dx.doi.org/10.1016/S0165-0173(99)00047-8>10.1016/S0165-0173(99)00047-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Nairn AC, Svenningsson P, Nishi A, Fisone G, Girault JA, Greengard P. The role of DARPP-32 in the actions of drugs of abuse.<Emphasis Type="Italic">Neuropharmacology</Emphasis> 2004;47:14&#8211;23.</td><td><a href=http://dx.doi.org/10.1016/j.neuropharm.2004.05.010>10.1016/j.neuropharm.2004.05.010</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR48</td><td>BibArticle</td><td>Valjent E, Pascoli V, Svenningsson P, et al. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2005;102:491&#8211;496.</td><td><a href=http://dx.doi.org/10.1073/pnas.0408305102>10.1073/pnas.0408305102</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Bibb JA, Chen J, Taylor JR, et al. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.<Emphasis Type="Italic">Nature.</Emphasis> 2001;410:376&#8211;380.</td><td><a href=http://dx.doi.org/10.1038/35066591>10.1038/35066591</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR50</td><td>BibArticle</td><td>Liu FC, Graybiel AM. Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum.<Emphasis Type="Italic">Neuron.</Emphasis> 1996;17:1133&#8211;1144.</td><td><a href=http://dx.doi.org/10.1016/S0896-6273(00)80245-7>10.1016/S0896-6273(00)80245-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR51</td><td>BibArticle</td><td>Hagiwara M, Alberts A, Brindle P, et al. Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB.<Emphasis Type="Italic">Cell.</Emphasis> 1992;70:105&#8211;113.</td><td><a href=http://dx.doi.org/10.1016/0092-8674(92)90537-M>10.1016/0092-8674(92)90537-M</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR52</td><td>BibArticle</td><td>Yan Z, Feng J, Fienberg AA, Greengard P. D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1999;96:11607&#8211;11612.</td><td><a href=http://dx.doi.org/10.1073/pnas.96.20.11607>10.1073/pnas.96.20.11607</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR53</td><td>BibArticle</td><td>Svenningsson P, Fienberg AA, Allen PB, et al. Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32.<Emphasis Type="Italic">J Neurochem.</Emphasis> 2000;75:248&#8211;257.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.2000.0750248.x>10.1046/j.1471-4159.2000.0750248.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR54</td><td>BibArticle</td><td>Hiroi N, Fienberg AA, Haile CN, et al. Neuronal and behavioral abnormalities in striatal function in DARPP-32-mutant mice.<Emphasis Type="Italic">Eur J Neurosci.</Emphasis> 1999;11:1114&#8211;1118.</td><td><a href=http://dx.doi.org/10.1046/j.1460-9568.1999.00570.x>10.1046/j.1460-9568.1999.00570.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR55</td><td>BibArticle</td><td>Zachariou V, Benoit-Marand M, Allen PB, et al. Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP32 or Inhibitor 1.<Emphasis Type="Italic">Biol Psychiatry.</Emphasis> 2002;51:612&#8211;620.</td><td><a href=http://dx.doi.org/10.1016/S0006-3223(01)01318-X>10.1016/S0006-3223(01)01318-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR56</td><td>BibArticle</td><td>Heyser CJ, Fienberg AA, Greengard P, Gold LH. DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task.<Emphasis Type="Italic">Brain Res.</Emphasis> 2000;867:122&#8211;130.</td><td><a href=http://dx.doi.org/10.1016/S0006-8993(00)02272-1>10.1016/S0006-8993(00)02272-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR57</td><td>BibArticle</td><td>Schoffelmeer AN, Hansen HA, Stoof JC, Mulder AH. Blockade of D-2 dopamine receptors trongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1986;6:2235&#8211;2239.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR58</td><td>BibArticle</td><td>Georges F, Stinus L, Bloch B, Le Moine C. Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum.<Emphasis Type="Italic">Eur J Neurosci.</Emphasis> 1999;11:481&#8211;490.</td><td><a href=http://dx.doi.org/10.1046/j.1460-9568.1999.00462.x>10.1046/j.1460-9568.1999.00462.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR59</td><td>BibArticle</td><td>Lindskog M, Svenningsson P, Fredholm B, Greengard P, Fisone G. Mu- and delta-opioid receptor agonists inhibit DARPP-32 phosphorylation in distinct populations of striatal projection neurons.<Emphasis Type="Italic">Eur J Neurosci.</Emphasis> 1999;11:2182&#8211;2186.</td><td><a href=http://dx.doi.org/10.1046/j.1460-9568.1999.00597.x>10.1046/j.1460-9568.1999.00597.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR60</td><td>BibArticle</td><td>Role LW, Berg DK. Nicotinic receptors in the development and modulation of CNS synapses.<Emphasis Type="Italic">Neuron.</Emphasis> 1996;16:1077&#8211;1085.</td><td><a href=http://dx.doi.org/10.1016/S0896-6273(00)80134-8>10.1016/S0896-6273(00)80134-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR61</td><td>BibArticle</td><td>Wonnacott S. Presynaptic nicotinic ACh receptors.<Emphasis Type="Italic">Trends Neurosci.</Emphasis> 1997;20:92&#8211;98.</td><td><a href=http://dx.doi.org/10.1016/S0166-2236(96)10073-4>10.1016/S0166-2236(96)10073-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR62</td><td>BibChapter</td><td>Ramirez-Latorre J, Crabtree G, Turner J, Role L. Molecular composition and biophysical characteristics of nicotinic receptors. In: Arneric SP, Brioni JD, eds.<Emphasis Type="Italic">Neuronal nicotinic receptors: pharmacology and therapeutic opportunities</Emphasis>. New York: Wiley-Liss, Inc, 1999:43&#8211;64.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR63</td><td>BibArticle</td><td>Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, Gotti C. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum.<Emphasis Type="Italic">J Neurosci.</Emphasis> 2002;22:8785&#8211;8789.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR64</td><td>BibArticle</td><td>Nomikos GG, Schilstrom B, Hildebrand BE, Panagis G, Grenhoff J, Svensson TH. Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness.<Emphasis Type="Italic">Behav Brain Res.</Emphasis> 2000;113:97&#8211;103.</td><td><a href=http://dx.doi.org/10.1016/S0166-4328(00)00204-7>10.1016/S0166-4328(00)00204-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR65</td><td>BibArticle</td><td>Hamada M, Higashi H, Nairn AC, Greengard P, Nishi A. Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons.<Emphasis Type="Italic">J Neurochem.</Emphasis> 2004;90:1094&#8211;1103.</td><td><a href=http://dx.doi.org/10.1111/j.1471-4159.2004.02574.x>10.1111/j.1471-4159.2004.02574.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR66</td><td>BibArticle</td><td>Aghajanian GK, Marek GJ. Serotonin and hallucinogens.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 1999;21:16S-23S.</td><td><a href=http://dx.doi.org/10.1016/S0893-133X(98)00135-3>10.1016/S0893-133X(98)00135-3</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, ArticleTitle, FirstPage, JournalTitle, VolumeID</td><td>CrossRef</td></tr><tr><td>CR67</td><td>BibArticle</td><td>Grailhe R, Waeber C, Dulawa SC, et al. Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor.<Emphasis Type="Italic">Neuron.</Emphasis> 1999;22:581&#8211;591.</td><td><a href=http://dx.doi.org/10.1016/S0896-6273(00)80712-6>10.1016/S0896-6273(00)80712-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR68</td><td>BibArticle</td><td>Glennon RA, Titeler M, McKenney JD. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.<Emphasis Type="Italic">Life Sci.</Emphasis> 1984;35:2505&#8211;2511.</td><td><a href=http://dx.doi.org/10.1016/0024-3205(84)90436-3>10.1016/0024-3205(84)90436-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR69</td><td>BibArticle</td><td>Sawa A, Snyder SH. Schizophrenia: diverse approaches to a complex disease.<Emphasis Type="Italic">Science</Emphasis>. 2002;296:692&#8211;695.</td><td><a href=http://dx.doi.org/10.1126/science.1070532>10.1126/science.1070532</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR70</td><td>BibArticle</td><td>Carlezon WA Jr, Wise RA. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex.<Emphasis Type="Italic">J Neurosci.</Emphasis> 1996;16:3112&#8211;3122.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR71</td><td>BibArticle</td><td>Druhan JP, Rajabi H, Stewart J. MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens.<Emphasis Type="Italic">Synapse.</Emphasis> 1996;24:135&#8211;146.</td><td><a href=http://dx.doi.org/10.1002/(SICI)1098-2396(199610)24:2&lt;135::AID-SYN5&gt;3.0.CO;2-G>10.1002/(SICI)1098-2396(199610)24:2&lt;135::AID-SYN5&gt;3.0.CO;2-G</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR72</td><td>BibArticle</td><td>Pierce RC, Meil WM, Kalivas PW. The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission.<Emphasis Type="Italic">Psychopharmacology (Berl).</Emphasis> 1997;133:188&#8211;195.</td><td><a href=http://dx.doi.org/10.1007/s002130050390>10.1007/s002130050390</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR73</td><td>BibArticle</td><td>Svenningsson P, Le Moine C, Fisone G, Fredholm BB. Distribution, biochemistry and function of striatal adenosine A2A receptors.<Emphasis Type="Italic">Prog Neurobiol.</Emphasis> 1999;59:355&#8211;396.</td><td><a href=http://dx.doi.org/10.1016/S0301-0082(99)00011-8>10.1016/S0301-0082(99)00011-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR74</td><td>BibArticle</td><td>Ledent C, Vaugeois JM, Schiffmann SN, et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor.<Emphasis Type="Italic">Nature.</Emphasis> 1997;388:674&#8211;678.</td><td><a href=http://dx.doi.org/10.1038/41771>10.1038/41771</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR75</td><td>BibArticle</td><td>Risinger FO, Freeman PA, Greengard P, Fienberg AA. Motivational effects of ethanol in DARPP-32 knock-out mice.<Emphasis Type="Italic">J Neurosci.</Emphasis> 2001;21:340&#8211;348.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR76</td><td>BibArticle</td><td>Maldve RE, Zhang TA, Ferrani-Kile K, et al. DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens.<Emphasis Type="Italic">Nat Neurosci.</Emphasis> 2002;5:641&#8211;648.</td><td><a href=http://dx.doi.org/10.1038/nn877>10.1038/nn877</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>